Frontlight ResearchEarly access
Trial site
National Cheng-Kung Uni. Hosp.
- 8running trials
- 1closed trial
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Liver and biliary tract cancer2 trials
- Obesity2 trials
- Chronic lymphocytic leukaemia1 trial
- Colorectal cancer1 trial
- Endometrial cancer1 trial
- Glioblastoma1 trial
- Lung cancer1 trial
- Mantle cell lymphoma1 trial
- Melanoma1 trial
- Metastatic breast cancer1 trial
- Obstructive sleep apnoea1 trial
- Prostate cancer1 trial
- and 4 more
- Phase
- Phase 36 trials
- Phase 12 trials
- Phase 21 trial
- Status
- Active, not recruiting6 trials
- Completed1 trial
- Not yet recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Eli Lilly and Company7 trials
- Loxo Oncology, Inc.2 trials
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
Active, not recruiting
Active, not recruiting
A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity2 recruiting
- Obstructive sleep apnoea1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 14 Nov 2026